Grandview Asset Management’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
Grandview Asset Management's LLY Position: Q3 2026 in Review
Grandview Asset Management reduced its Eli Lilly (LLY) stake by 22% in Q3 2026, selling an estimated $517K and leaving 1,538 shares worth $1.78M. The position accounts for 0.49% of the portfolio, ranked #35.
Grandview Asset Management first reported a position in LLY in Q1 2021 and has held it in 11 quarters since. The position peaked at $2.39M in Q2 2026. 4,626 funds tracked by Wall St. Rank hold LLY as of Q3 2026.
- Grandview Asset Management held 1,538 shares of Eli Lilly worth $1.78M as of Q3 2026.
- Grandview Asset Management sold 438 Eli Lilly shares in Q3 2026, an estimated $517K.
- Eli Lilly made up 0.49% of Grandview Asset Management's portfolio in Q3 2026, its #35 holding.
- Grandview Asset Management first reported a position in Eli Lilly in Q1 2021 and has held it in 11 quarters since.
- Grandview Asset Management's Eli Lilly position peaked at $2.39M in Q2 2026.
- 4,626 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.
Based on Grandview Asset Management's 13F filing for Q3 2026, filed 19 Oct 2026.